Literature DB >> 11476842

Unexpected healing of cutaneous ulcers in a short child.

R Cimaz, R Rusconi, E Fossali, P Careddu.   

Abstract

A boy aged 10 years was referred to the Paediatric Department of Milan University Hospital, Milan, Italy, with a long history of pain in the lower limbs, alleviated only by exposure to cold. His legs were swollen, with multiple cutaneous ulcers. He had severe painful crises, and was totally incapacitated. After the diagnosis of erythermalgia was made, numerous treatments were tried, but none were successful. After finding growth hormone (GH) deficiency, we started treatment with recombinant GH. He had immediate relief of pain and complete healing of ulcers. We postulate that the healing of the ulcers can be attributed to the GH-promoting effect on dermal connective tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476842     DOI: 10.1016/S0140-6736(01)05413-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Henry VIII's obesity following traumatic brain injury.

Authors:  Hutan Ashrafian
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

3.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  Early Life Nociception is Influenced by Peripheral Growth Hormone Signaling.

Authors:  Adam J Dourson; Zachary K Ford; Kathryn J Green; Carolyn E McCrossan; Megan C Hofmann; Renita C Hudgins; Michael P Jankowski
Journal:  J Neurosci       Date:  2021-04-22       Impact factor: 6.167

5.  Growth hormone regulates the sensitization of developing peripheral nociceptors during cutaneous inflammation.

Authors:  Xiaohua Liu; Kathryn J Green; Zachary K Ford; Luis F Queme; Peilin Lu; Jessica L Ross; Frank B Lee; Aaron T Shank; Renita C Hudgins; Michael P Jankowski
Journal:  Pain       Date:  2017-02       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.